Literature DB >> 18769355

Incidence and characterization of acute HIV-1 infection in a high-risk Thai population.

Jintanat Ananworanich1, Nittaya Phanuphak, Mark de Souza, Robert Paris, Miguel Arroyo, Rapee Trichavaroj, Sunee Sirivichayakul, Cecilia Shikuma, Praphan Phanuphak, Jerome H Kim.   

Abstract

OBJECTIVE: The objective of this study was to investigate the incidence, demographics, HIV subtype, and genotypic resistance of acute HIV infections in a high-risk Thai population.
METHODS: Between March 2006 and September 2007, 6426 stored samples at the Thai Red Cross Anonymous Clinic were screened for acute HIV infection by 2 methods: pooled nucleic acid testing (NAT) of fourth-generation enzyme immunoassay (EIA)-negative samples (n = 5402) and subsequent first-generation EIA testing of fourth-generation EIA-positive samples (n = 1024).
RESULTS: Eleven acute HIV-infected subjects were identified by pooled NAT (n = 7) and serial EIA (n = 4). Mean age was 28 years; 9 were male; and 60% were men who have sex with men. Median HIV RNA was 99,601 copies per milliliter (log10 viral load (VL) = 5.00). Eight samples could be genotyped: 6, CRF01_AE; 1, subtype B; and 1, CRF01_AE/B recombinant. No resistance to antiretroviral therapy was found. The HIV incidence per 100 person-years, calculated from the pooled, antibody-negative samples, was 2.7% (95% confidence interval, 2.2%-4.3%).
CONCLUSIONS: This is the first report of antibody-negative, NAT-positive, acute HIV infection in Thailand. The majority were men who have sex with men, which reflects the current epidemic in Thailand and justifies prevention programs aimed at this group. This high-risk population may be suitable for future studies on acute HIV infection, HIV treatment, vaccine, and prevention of onward transmission strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769355     DOI: 10.1097/QAI.0b013e318183a96d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  25 in total

Review 1.  HIV vaccines: lessons learned and the way forward.

Authors:  Jerome H Kim; Supachai Rerks-Ngarm; Jean-Louis Excler; Nelson L Michael
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

2.  Why we need pre-exposure prophylaxis: incident HIV and syphilis among men, and transgender women, who have sex with men, Bangkok, Thailand, 2005-2015.

Authors:  T H Holtz; W Wimonsate; P A Mock; S Pattanasin; W Chonwattana; W Thienkrua; W Sukwicha; M E Curlin; A Chitwarakorn; E F Dunne
Journal:  Int J STD AIDS       Date:  2019-01-09       Impact factor: 1.359

3.  Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.

Authors:  Irini Sereti; Shelly J Krebs; Nittaya Phanuphak; James L Fletcher; Bonnie Slike; Suteeraporn Pinyakorn; Robert J O'Connell; Adam Rupert; Nicolas Chomont; Victor Valcour; Jerome H Kim; Merlin L Robb; Nelson L Michael; Daniel C Douek; Jintanat Ananworanich; Netanya S Utay
Journal:  Clin Infect Dis       Date:  2016-10-12       Impact factor: 9.079

4.  Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.

Authors:  Michael J Peluso; Victor Valcour; Jintanat Ananworanich; Pasiri Sithinamsuwan; Thep Chalermchai; James L K Fletcher; Sukalya Lerdlum; Nitiya Chomchey; Bonnie Slike; Napapon Sailasuta; Magnus Gisslén; Henrik Zetterberg; Serena Spudich
Journal:  J Infect Dis       Date:  2015-05-20       Impact factor: 5.226

5.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

6.  High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.

Authors:  Cari F Kessing; Serena Spudich; Victor Valcour; Pearline Cartwright; Thep Chalermchai; James L K Fletcher; Hiroshi Takata; Carmen Nichols; Benjamin J Josey; Bonnie Slike; Shelly J Krebs; Napapon Sailsuta; Sukalaya Lerdlum; Linda Jagodzinski; Somporn Tipsuk; Duanghathai Suttichom; Somprartthana Rattanamanee; Henrik Zetterberg; Joanna Hellmuth; Nittaya Phanuphak; Merlin L Robb; Nelson L Michael; Jintanat Ananworanich; Lydie Trautmann
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

7.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

8.  Impact of early cART in the gut during acute HIV infection.

Authors:  Claire Deleage; Alexandra Schuetz; W Gregory Alvord; Leslie Johnston; Xing-Pei Hao; David R Morcock; Rungsun Rerknimitr; James L K Fletcher; Suwanna Puttamaswin; Nittaya Phanuphak; Robin Dewar; Joseph M McCune; Irini Sereti; Merlin Robb; Jerome H Kim; Timothy W Schacker; Peter Hunt; Jeffrey D Lifson; Jintanat Ananworanich; Jacob D Estes
Journal:  JCI Insight       Date:  2016-07-07

9.  Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.

Authors:  Idil Kore; Jintanat Ananworanich; Victor Valcour; James L K Fletcher; Thep Chalermchai; Robert Paul; Jesse Reynolds; Somporn Tipsuk; Sasiwimol Ubolyam; Somprartthana Rattanamanee; Linda Jagodzinski; Jerome Kim; Serena Spudich
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

10.  Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.

Authors:  Michelle L D'Antoni; Mary Margaret Byron; Phillip Chan; Napapon Sailasuta; Carlo Sacdalan; Pasiri Sithinamsuwan; Somporn Tipsuk; Suteeraporn Pinyakorn; Eugene Kroon; Bonnie M Slike; Shelly J Krebs; Vedbar S Khadka; Thep Chalermchai; Kalpana J Kallianpur; Merlin Robb; Serena Spudich; Victor Valcour; Jintanat Ananworanich; Lishomwa C Ndhlovu
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.